Pregled bibliografske jedinice broj: 637173
Low-grade inflammation and iron metabolism in chronic kidney disease (CKD) patients
Low-grade inflammation and iron metabolism in chronic kidney disease (CKD) patients // Abstracts of the 2nd European Joint Congress of EFLM and UEMS "Laboratory Medicine at the Clinical Interface"
Zagreb: Croatian Society for Medical Biochemistry and Laboratory Medicine, 2012. str. A138-A139 (poster, međunarodna recenzija, sažetak, stručni)
CROSBI ID: 637173 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Low-grade inflammation and iron metabolism in chronic kidney disease (CKD) patients
Autori
Tandara, Leida ; Salamunić, Ilza ; Gugo, Katarina ; Bilopavlović, Nada ; Pauković-Sekulić, Branka ; Tandara, Marijan
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, stručni
Izvornik
Abstracts of the 2nd European Joint Congress of EFLM and UEMS "Laboratory Medicine at the Clinical Interface"
/ - Zagreb : Croatian Society for Medical Biochemistry and Laboratory Medicine, 2012, A138-A139
Skup
2nd European Joint Congress of EFLM and UEMS "Laboratory Medicine at the Clinical Interface"
Mjesto i datum
Dubrovnik, Hrvatska, 10.10.2012. - 13.10.2012
Vrsta sudjelovanja
Poster
Vrsta recenzije
Međunarodna recenzija
Ključne riječi
Inflamation; iron; CKD
Sažetak
Background: Patients with CKD are exposed to persistent low-grade inflammation. Increased level of proinflammatory cytokines cause cellular iron retention and repress iron efflux from sites of main iron flow into the blood reducing thus iron availablity and contributing to development of anemia in CKD patients. This study aimed to assess relationship between indicators of inflammation and routine biochemical markers of iron metabolism as well as hematological indicators of iron availability in group of HD patients with low-grade inflammation (defined as CRP < 15 mg/L, without clinical manifestation of inflammation). Materials and methods: The study was conducted in 45 HD patients and 21 healthy subjects. Biochemical markers (serum iron, transferrin, transferrin saturation, ferritin), haematological indexes (%Hypo and CHr) were determined by routine laboratory methods. As inflammatory markers, CRP and hsIL-6 were determined. Results: Levels of serum CRP (2.9 (0.9-10.9) vs. 0.8 (0.4-3.2) mg/L) and IL-6 (5.03 (1.69-10.5 vs. 1.20 (0.14-10.55 ng/L) were significantly higher in HD patients compared with control group (P < 0.05). We found a statistically significant (P < 0.05) lower level of serum iron, transferrin, transferrin saturation and higher level of ferritin and %Hypo but there were no significant correlations between CRP/IL-6 and biochemical markers of iron status or hematological indexes in HD group. Conclusion: Parameters of iron metabolism are changed but inflammation indicators do not correlate with parameters of iron metabolism in our studied group. Since levels of serum inflammatory markers are subjected to a substantial variability over time repeated versus single measurements in a future studies could give a more valuable information about examined relationship.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Ustanove:
KBC Split
Citiraj ovu publikaciju:
Časopis indeksira:
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE